TY - JOUR
T1 - Predicting outcome in patients with anti-GBM glomerulonephritis
AU - van Daalen, Emma
AU - Jennette, J. Charles
AU - McAdoo, Stephen P.
AU - Pusey, Charles D.
AU - Alba, Marco A.
AU - Poulton, Caroline J.
AU - Wolterbeek, Ron
AU - Nguyen, Tri Q.
AU - Goldschmeding, Roel
AU - Alchi, Bassam
AU - Griffiths, Meryl
AU - de Zoysa, Janak R.
AU - Vincent, Beula
AU - Bruijn, Jan A
AU - Bajema, Ingeborg M
N1 - Funding Information:
E.E.v.D. is a student supported by the Kolff Student Researcher GrantfromtheDutchKidneyFoundation.M.A.A.wassupportedby Consejo Nacional de Ciencia y Tecnología, Mexico. S.P.M. and C.D.P. were supported by the National Institute for Health Research Imperial Biomedical Research Centre.
Funding Information:
E.E.v.D. is a student supported by the Kolff Student Researcher Grant from the Dutch Kidney Foundation. M.A.A.was supported by Consejo Nacional de Ciencia y Tecnología, Mexico. S.P.M. and C.D.P. were supported by the NIHRNational Institute for Health Research Imperial Biomedical Research Centre.
Publisher Copyright:
© 2018 by the American Society of Nephrology.
PY - 2018/1/6
Y1 - 2018/1/6
N2 - Background and objectives Large studies on long-term kidney outcome in patients with anti-glomerular basement membrane (anti-GBM) GN are lacking. This study aimed to identify clinical and histopathologic parameters that predict kidney outcome in these patients. Design, setting, participants, &measurements This retrospective analysis included a total of 123 patients with anti-GBM GN between 1986 and 2015 from six centers worldwide. Their kidney biopsy samples were classified according to the histopathologic classification for ANCA-associated GN. Clinical data such as details of treatment were retrieved from clinical records. The primary outcome parameter was the occurrence of ESRD. Kidney survival was analyzed using the log-rank test and Cox regression analyses. Results The 5-year kidney survival rate was 34%, with an improved rate observed among patients diagnosed after 2007 (P=0.01). In patients with anti-GBM GN, histopathologic class and kidney survival were associated (P˂ 0.001). Only one of 15 patients with a focal class biopsy sample (≥50% normal glomeruli) developed ESRD. Patients with a sclerotic class biopsy sample (≥50% globally sclerotic glomeruli) and patients with 100% cellular crescents did not recover from dialysis dependency at presentation. Inmultivariable analysis, dialysis dependency at presentation (hazard ratio [HR], 3.17; 95% confidence interval [95% CI], 1.59 to 6.32), percentage of normal glomeruli (HR, 0.97; 95% CI, 0.95 to 0.99), and extent of interstitial infiltrate (HR, 2.02; 95% CI, 1.17 to 3.50) were predictors of ESRD during follow-up. Conclusions Dialysis dependency, low percentage of normal glomeruli, and large extent of interstitial infiltrate are associated with poor kidney outcome in anti-GBM GN. Kidney outcome has improved during recent years; the success rate doubled after 2007.
AB - Background and objectives Large studies on long-term kidney outcome in patients with anti-glomerular basement membrane (anti-GBM) GN are lacking. This study aimed to identify clinical and histopathologic parameters that predict kidney outcome in these patients. Design, setting, participants, &measurements This retrospective analysis included a total of 123 patients with anti-GBM GN between 1986 and 2015 from six centers worldwide. Their kidney biopsy samples were classified according to the histopathologic classification for ANCA-associated GN. Clinical data such as details of treatment were retrieved from clinical records. The primary outcome parameter was the occurrence of ESRD. Kidney survival was analyzed using the log-rank test and Cox regression analyses. Results The 5-year kidney survival rate was 34%, with an improved rate observed among patients diagnosed after 2007 (P=0.01). In patients with anti-GBM GN, histopathologic class and kidney survival were associated (P˂ 0.001). Only one of 15 patients with a focal class biopsy sample (≥50% normal glomeruli) developed ESRD. Patients with a sclerotic class biopsy sample (≥50% globally sclerotic glomeruli) and patients with 100% cellular crescents did not recover from dialysis dependency at presentation. Inmultivariable analysis, dialysis dependency at presentation (hazard ratio [HR], 3.17; 95% confidence interval [95% CI], 1.59 to 6.32), percentage of normal glomeruli (HR, 0.97; 95% CI, 0.95 to 0.99), and extent of interstitial infiltrate (HR, 2.02; 95% CI, 1.17 to 3.50) were predictors of ESRD during follow-up. Conclusions Dialysis dependency, low percentage of normal glomeruli, and large extent of interstitial infiltrate are associated with poor kidney outcome in anti-GBM GN. Kidney outcome has improved during recent years; the success rate doubled after 2007.
KW - ANCA
KW - Anti-GBM disease
KW - Antibodies antineutrophil
KW - Antiglomerular basement membrane antibody
KW - Autoantibodies
KW - Biopsy
KW - Confidence intervals
KW - Cytoplasmic
KW - Follow-Up studies
KW - Glomerular basement membrane
KW - Glomerulonephritis
KW - Goodpasture-s syndrome
KW - Kidney
KW - Kidney biopsy
KW - Kidney failure chronic
KW - Multivariate analysis
KW - Regression analysis
KW - Renal dialysis
KW - Retrospective studies
KW - Survival rate
UR - http://www.scopus.com/inward/record.url?scp=85040246309&partnerID=8YFLogxK
U2 - 10.2215/CJN.04290417
DO - 10.2215/CJN.04290417
M3 - Article
AN - SCOPUS:85040246309
SN - 1555-9041
VL - 13
SP - 63
EP - 72
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 1
ER -